Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth.
Successful virotherapy requires efficient virus spread within tumors. We tested whether the expression of hyaluronidase, an enzyme which dissociates the extracellular matrix (ECM), could enhance the intratumoral distribution of an oncolytic adenovirus and improve its therapeutic activity. As a proof of concept, we demonstrated that intratumoral coadministration of hyaluronidase in mice-bearing tumor xenografts improves the antitumor activity of an oncolytic adenovirus. Next, we constructed a replication-competent adenovirus expressing a soluble form of the human sperm hyaluronidase (PH20) under the control of the major late promoter (MLP) (AdwtRGD-PH20). Intratumoral treatment of human melanoma xenografts with AdwtRGD-PH20 resulted in degradation of hyaluronan (HA), enhanced viral distribution, and induced tumor regression in all treated tumors. Finally, the PH20 cDNA was inserted in an oncolytic adenovirus that selectively kills pRb pathway-defective tumor cells. The antitumoral activity of the novel oncolytic adenovirus expressing PH20 (ICOVIR17) was compared to that of the parental virus ICOVIR15. ICOVIR17 showed more antitumor efficacy following intratumoral and systemic administration in mice with prestablished tumors, along with an improved spread of the virus within the tumor. Importantly, a single intravenous dose of ICOVIR17 induced tumor regression in 60% of treated tumors. These results indicate that ICOVIR17 is a promising candidate for clinical testing.
Guedan
Sonia
S
Translational Research Laboratory, IDIBELL-Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
Rojas
Juan José
JJ
Gros
Alena
A
Mercade
Elena
E
Cascallo
Manel
M
Alemany
Ramon
R
D000256:Adenoviridae / Q000235:genetics / Q000502:physiology*; D000818:Animals; D002417:Cattle; D002460:Cell Line; D045744:Cell Line, Tumor; D006224:Cricetinae; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000235:genetics / Q000378:metabolism*; D007150:Immunohistochemistry; D008297:Male; D008545:Melanoma / Q000628:therapy; D008647:Mesocricetus; D051379:Mice; D008807:Mice, Inbred BALB C; D050130:Oncolytic Virotherapy; D023041:Xenograft Model Antitumor Assays
D006821:Hyaluronoglucosaminidase